Pioneering transformational drug discovery and development in the areas of cancer and fibrosis
RXC004 – Entering clinical development in early 2018
Pioneering transformational drug discovery and development in the areas of cancer and fibrosis
Lead fibrosis programme – Pan-ROCK inhibitor for fibrosis related to IBD
GBX 21.00GBp
LON : REDX 20/11/2017 03:42AM

Drug discovery and development business creating high value cancer and fibrosis therapeutics

More about Redx Pharma